These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8084925)

  • 1. Shifting depression.
    Campbell IC; Marsden K; Powell JF
    Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent evaluation of new drugs.
    Ball CJ
    Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
    [No Abstract]   [Full Text] [Related]  

  • 3. Noradrenergic and serotoninergic depression?
    Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
    J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action of antidepressants].
    Llorca PM; Reine G; Wolf MA
    Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Status of amine hypotheses in depressive disorders].
    Fritze J; Deckert J; Lanczik M; Strik W; Struck M; Wodarz N
    Nervenarzt; 1992 Jan; 63(1):3-13. PubMed ID: 1314964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
    Fillion G
    Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
    [No Abstract]   [Full Text] [Related]  

  • 8. Dysthymia and serotonin.
    Lapierre YD; Ravindran A; Bakish D
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
    [No Abstract]   [Full Text] [Related]  

  • 9. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
    Haddjeri N; Blier P; de Montigny C
    Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():11-7. PubMed ID: 8930005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
    Stahl SM
    J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
    Andrews JM; Ninan PT; Nemeroff CB
    Depression; 1996; 4(2):48-56. PubMed ID: 9160640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression.
    Sulser F; Janowsky AJ; Okada F; Manier DH; Mobley PL
    Neuropharmacology; 1983 Mar; 22(3 Spec No):425-31. PubMed ID: 6304560
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there action beyond receptors?
    Hrdina PD
    J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
    [No Abstract]   [Full Text] [Related]  

  • 15. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
    Sulser F
    J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Noradrenergic and serotoninergic brain structures and the auditory analyzer].
    Khanbabian MV; Davtian MM
    Usp Fiziol Nauk; 1988; 19(1):118-24. PubMed ID: 2834889
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant mechanisms.
    Goldstein S
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142. PubMed ID: 8138512
    [No Abstract]   [Full Text] [Related]  

  • 18. The marketing of 5-hydroxytryptamine: depression or anxiety?
    Healy D
    Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
    [No Abstract]   [Full Text] [Related]  

  • 19. Antidepressant treatment and side effect considerations.
    Tollefson GD
    J Clin Psychiatry; 1991 May; 52 Suppl():4-13. PubMed ID: 2030103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norepinephrine dysfunction in depression.
    Anand A; Charney DS
    J Clin Psychiatry; 2000; 61 Suppl 10():16-24. PubMed ID: 10910013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.